Literature DB >> 11473504

The epidemiology of perimenstrual psychological symptoms.

J Angst1, R Sellaro, K R Merikangas, J Endicott.   

Abstract

OBJECTIVE: The purpose of this paper is to examine the prevalence, clinical significance and comorbidity of perimenstrual symptoms/syndrome (PERI-MS) in a community sample of women.
METHOD: Premenstrual and menstrual physical and psychological symptoms were assessed in a prospective longitudinal study of a representative community cohort of women (N=299) who were interviewed five times between the ages of 21 and 35 years.
RESULTS: When classified according to the severity of distress, the prevalence rates were 8.1% for severe and 13.6% for moderate PERI-MS, respectively. Clinical indicators of severity were all greater among PERI-MS women with than without depressed mood.
CONCLUSION: The results of this study suggest that irritability, nervousness and tension irrespective of the presence of concomitant depressed mood are core elements of the perimenstrual syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11473504     DOI: 10.1034/j.1600-0447.2001.00412.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  63 in total

Review 1.  Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

Review 2.  Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis.

Authors:  Maria Kleinstäuber; Michael Witthöft; Wolfgang Hiller
Journal:  J Clin Psychol Med Settings       Date:  2012-09

Review 3.  Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Authors:  Ellen W Freeman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Increased childhood abuse in patients with premenstrual dysphoric disorder in a Turkish sample: a cross-sectional study.

Authors:  Esra Akyol Soydas; Yakup Albayrak; Basak Sahin
Journal:  Prim Care Companion CNS Disord       Date:  2014-07-24

5.  Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women.

Authors:  Jin Pyo Hong; Subin Park; Hee-Ryung Wang; Sung Man Chang; Jee Hoon Sohn; Hong Jin Jeon; Hae Woo Lee; Seong-Jin Cho; Byung-Soo Kim; Jae Nam Bae; Maeng Je Cho
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-27       Impact factor: 4.328

6.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

7.  Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.

Authors:  Cheryl A Frye
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

8.  [SIPS--screening instrument for premenstrual symptoms. The German version of Premenstrual Symptoms Screening Tool to assess clinically relevant disturbances].

Authors:  D Bentz; M Steiner; G Meinlschmidt
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

9.  Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.

Authors:  Eynav E Accortt; Anya V Kogan; John J B Allen
Journal:  J Affect Disord       Date:  2013-06-22       Impact factor: 4.839

10.  Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue.

Authors:  Doerte U Junghaenel; Stefan Schneider; Arthur A Stone; Christopher Christodoulou; Joan E Broderick
Journal:  J Psychosom Res       Date:  2014-02-07       Impact factor: 3.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.